Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 137 entries
Sorted by: Best Match Show Resources per page
Marginal methods for clustered longitudinal binary data with incomplete covariates.

Journal of statistical planning and inference

Chen B, Yi GY, Cook RJ, Zhou XH.
PMID: 23805025
J Stat Plan Inference. 2012 Oct;142(10):2819-2831. doi: 10.1016/j.jspi.2012.04.006.

Many analyses for incomplete longitudinal data are directed to examining the impact of covariates on the marginal mean responses. We consider the setting in which longitudinal responses are collected from individuals nested within clusters. We discuss methods for assessing...

Cite
Chen B, Yi GY, Cook RJ, et al. Marginal methods for clustered longitudinal binary data with incomplete covariates. J Stat Plan Inference. 2012;142(10):2819-2831doi: 10.1016/j.jspi.2012.04.006.
Chen, B., Yi, G. Y., Cook, R. J., & Zhou, X. H. (2012). Marginal methods for clustered longitudinal binary data with incomplete covariates. Journal of statistical planning and inference, 142(10), 2819-2831. https://doi.org/10.1016/j.jspi.2012.04.006
Chen, Baojiang, et al. "Marginal methods for clustered longitudinal binary data with incomplete covariates." Journal of statistical planning and inference vol. 142,10 (2012): 2819-2831. doi: https://doi.org/10.1016/j.jspi.2012.04.006
Chen B, Yi GY, Cook RJ, Zhou XH. Marginal methods for clustered longitudinal binary data with incomplete covariates. J Stat Plan Inference. 2012 Oct;142(10):2819-2831. doi: 10.1016/j.jspi.2012.04.006. PMID: 23805025; PMCID: PMC3690662.
Copy Download .nbib Format: NLM
Trace Ratio Linear Discriminant Analysis for Medical Diagnosis: A Case Study of Dementia.

IEEE signal processing letters

Zhao M, Chan RH, Tang P, Chow TW, Wong SW.
PMID: 24077217
IEEE Signal Process Lett. 2013 Mar 07;20(5):431-434. doi: 10.1109/LSP.2013.2250281.

Dementia is one of the most common neurological disorders among the elderly. Identifying those who are of high risk suffering dementia is important to the administration of early treatment in order to slow down the progression of dementia symptoms....

Cite
Zhao M, Chan RH, Tang P, et al. Trace Ratio Linear Discriminant Analysis for Medical Diagnosis: A Case Study of Dementia. IEEE Signal Process Lett. 2013;20(5):431-434doi: 10.1109/LSP.2013.2250281.
Zhao, M., Chan, R. H., Tang, P., Chow, T. W., & Wong, S. W. (2013). Trace Ratio Linear Discriminant Analysis for Medical Diagnosis: A Case Study of Dementia. IEEE signal processing letters, 20(5), 431-434. https://doi.org/10.1109/LSP.2013.2250281
Zhao, Mingbo, et al. "Trace Ratio Linear Discriminant Analysis for Medical Diagnosis: A Case Study of Dementia." IEEE signal processing letters vol. 20,5 (2013): 431-434. doi: https://doi.org/10.1109/LSP.2013.2250281
Zhao M, Chan RH, Tang P, Chow TW, Wong SW. Trace Ratio Linear Discriminant Analysis for Medical Diagnosis: A Case Study of Dementia. IEEE Signal Process Lett. 2013 Mar 07;20(5):431-434. doi: 10.1109/LSP.2013.2250281. PMID: 24077217; PMCID: PMC3784002.
Copy Download .nbib Format: NLM
Neuropathologic correlates of trial-related instruments for Alzheimer's disease.

American journal of neurodegenerative disease

Cummings JL, Ringman J, Vinters HV.
PMID: 24754002
Am J Neurodegener Dis. 2014 Mar 28;3(1):45-9. eCollection 2014.

To advance disease-modifying therapies, it is critical to understand the relationship between the neuropathological changes of Alzheimer's Disease (AD) and the clinical measures used in therapeutic trials. We reviewed neuropathologically proven cases of AD from the National Alzheimer's Coordinating...

Cite
Cummings JL, Ringman J, Vinters HV. Neuropathologic correlates of trial-related instruments for Alzheimer's disease. Am J Neurodegener Dis. 2014;3(1):45-9
Cummings, J. L., Ringman, J., & Vinters, H. V. (2014). Neuropathologic correlates of trial-related instruments for Alzheimer's disease. American journal of neurodegenerative disease, 3(1), 45-9.
Cummings, Jeffrey L, et al. "Neuropathologic correlates of trial-related instruments for Alzheimer's disease." American journal of neurodegenerative disease vol. 3,1 (2014): 45-9.
Cummings JL, Ringman J, Vinters HV. Neuropathologic correlates of trial-related instruments for Alzheimer's disease. Am J Neurodegener Dis. 2014 Mar 28;3(1):45-9. eCollection 2014. PMID: 24754002; PMCID: PMC3986610.
Copy Download .nbib Format: NLM
Rates of lobar atrophy in asymptomatic .

Alzheimer's & dementia (New York, N. Y.)

Chen Q, Boeve BF, Senjem M, Tosakulwong N, Lesnick TG, Brushaber D, Dheel C, Fields J, Forsberg L, Gavrilova R, Gearhart D, Graff-Radford J, Graff-Radford NR, Jack CR, Jones DT, Knopman DS, Kremers WK, Lapid M, Rademakers R, Syrjanen J, Boxer AL, Rosen H, Wszolek ZK, Kantarci K.
PMID: 31388560
Alzheimers Dement (N Y). 2019 Jul 30;5:338-346. doi: 10.1016/j.trci.2019.05.010. eCollection 2019.

RESULTS: The rate of temporal lobe atrophy in asymptomatic DISCUSSION: Accelerated decline in temporal lobe volume occurs in asymptomatic

Cite
Chen Q, Boeve BF, Senjem M, et al. Rates of lobar atrophy in asymptomatic . Alzheimers Dement (N Y). 2019;5:338-346doi: 10.1016/j.trci.2019.05.010.
Chen, Q., Boeve, B. F., Senjem, M., Tosakulwong, N., Lesnick, T. G., Brushaber, D., Dheel, C., Fields, J., Forsberg, L., Gavrilova, R., Gearhart, D., Graff-Radford, J., Graff-Radford, N. R., Jack, C. R., Jones, D. T., Knopman, D. S., Kremers, W. K., Lapid, M., Rademakers, R., Syrjanen, J., Boxer, A. L., Rosen, H., Wszolek, Z. K., Kantarci, K. (2019). Rates of lobar atrophy in asymptomatic . Alzheimer's & dementia (New York, N. Y.), 5338-346. https://doi.org/10.1016/j.trci.2019.05.010
Chen, Qin, et al. "Rates of lobar atrophy in asymptomatic ." Alzheimer's & dementia (New York, N. Y.) vol. 5 (2019): 338-346. doi: https://doi.org/10.1016/j.trci.2019.05.010
Chen Q, Boeve BF, Senjem M, Tosakulwong N, Lesnick TG, Brushaber D, Dheel C, Fields J, Forsberg L, Gavrilova R, Gearhart D, Graff-Radford J, Graff-Radford NR, Jack CR, Jones DT, Knopman DS, Kremers WK, Lapid M, Rademakers R, Syrjanen J, Boxer AL, Rosen H, Wszolek ZK, Kantarci K. Rates of lobar atrophy in asymptomatic . Alzheimers Dement (N Y). 2019 Jul 30;5:338-346. doi: 10.1016/j.trci.2019.05.010. eCollection 2019. PMID: 31388560; PMCID: PMC6675939.
Copy Download .nbib Format: NLM
Detecting galaxy-filament alignments in the Sloan Digital Sky Survey III.

Monthly notices of the Royal Astronomical Society

Chen YC, Ho S, Blazek J, He S, Mandelbaum R, Melchior P, Singh S.
PMID: 30880842
Mon Not R Astron Soc. 2019 May;485(2):2492-2504. doi: 10.1093/mnras/stz539. Epub 2019 Feb 26.

Previous studies have shown the filamentary structures in the cosmic web influence the alignments of nearby galaxies. We study this effect in the LOWZ sample of the Sloan Digital Sky Survey using the 'Cosmic Web Reconstruction' filament catalogue. We...

Cite
Chen YC, Ho S, Blazek J, et al. Detecting galaxy-filament alignments in the Sloan Digital Sky Survey III. Mon Not R Astron Soc. 2019;485(2):2492-2504doi: 10.1093/mnras/stz539.
Chen, Y. C., Ho, S., Blazek, J., He, S., Mandelbaum, R., Melchior, P., & Singh, S. (2019). Detecting galaxy-filament alignments in the Sloan Digital Sky Survey III. Monthly notices of the Royal Astronomical Society, 485(2), 2492-2504. https://doi.org/10.1093/mnras/stz539
Chen, Yen-Chi, et al. "Detecting galaxy-filament alignments in the Sloan Digital Sky Survey III." Monthly notices of the Royal Astronomical Society vol. 485,2 (2019): 2492-2504. doi: https://doi.org/10.1093/mnras/stz539
Chen YC, Ho S, Blazek J, He S, Mandelbaum R, Melchior P, Singh S. Detecting galaxy-filament alignments in the Sloan Digital Sky Survey III. Mon Not R Astron Soc. 2019 May;485(2):2492-2504. doi: 10.1093/mnras/stz539. Epub 2019 Feb 26. PMID: 30880842; PMCID: PMC6408928.
Copy Download .nbib Format: NLM
APOE2 eases cognitive decline during Aging: Clinical and preclinical evaluations.

Annals of neurology

Shinohara M, Kanekiyo T, Yang L, Linthicum D, Shinohara M, Fu Y, Price L, Frisch-Daiello JL, Han X, Fryer JD, Bu G.
PMID: 26933942
Ann Neurol. 2016 May;79(5):758-774. doi: 10.1002/ana.24628. Epub 2016 Mar 29.

OBJECTIVE: Apolipoprotein E (apoE), a major cholesterol carrier in the brain, is associated with a strong risk for Alzheimer disease. Compared to the risky APOE4 gene allele, the effects of the protective APOE2 gene allele are vastly understudied, and...

Cite
Shinohara M, Kanekiyo T, Yang L, et al. APOE2 eases cognitive decline during Aging: Clinical and preclinical evaluations. Ann Neurol. 2016;79(5):758-774doi: 10.1002/ana.24628.
Shinohara, M., Kanekiyo, T., Yang, L., Linthicum, D., Shinohara, M., Fu, Y., Price, L., Frisch-Daiello, J. L., Han, X., Fryer, J. D., & Bu, G. (2016). APOE2 eases cognitive decline during Aging: Clinical and preclinical evaluations. Annals of neurology, 79(5), 758-774. https://doi.org/10.1002/ana.24628
Shinohara, Mitsuru, et al. "APOE2 eases cognitive decline during Aging: Clinical and preclinical evaluations." Annals of neurology vol. 79,5 (2016): 758-774. doi: https://doi.org/10.1002/ana.24628
Shinohara M, Kanekiyo T, Yang L, Linthicum D, Shinohara M, Fu Y, Price L, Frisch-Daiello JL, Han X, Fryer JD, Bu G. APOE2 eases cognitive decline during Aging: Clinical and preclinical evaluations. Ann Neurol. 2016 May;79(5):758-774. doi: 10.1002/ana.24628. Epub 2016 Mar 29. PMID: 26933942; PMCID: PMC5010530.
Copy Download .nbib Format: NLM
Polypharmacy in an Elderly Population: Enhancing Medication Management Through the Use of Clinical Decision Support Software Platforms.

Neurology and therapy

Keine D, Zelek M, Walker JQ, Sabbagh MN.
PMID: 30900186
Neurol Ther. 2019 Jun;8(1):79-94. doi: 10.1007/s40120-019-0131-6. Epub 2019 Mar 21.

INTRODUCTION: Polypharmacy is a growing problem in the United States. The use of multiple medications increases the likelihood that a patient will experience potential drug interactions and adverse drug reactions (ADRs). Those individuals with dementia or Alzheimer's disease (AD)...

Cite
Keine D, Zelek M, Walker JQ, et al. Polypharmacy in an Elderly Population: Enhancing Medication Management Through the Use of Clinical Decision Support Software Platforms. Neurol Ther. 2019;8(1):79-94doi: 10.1007/s40120-019-0131-6.
Keine, D., Zelek, M., Walker, J. Q., & Sabbagh, M. N. (2019). Polypharmacy in an Elderly Population: Enhancing Medication Management Through the Use of Clinical Decision Support Software Platforms. Neurology and therapy, 8(1), 79-94. https://doi.org/10.1007/s40120-019-0131-6
Keine, Dorothy, et al. "Polypharmacy in an Elderly Population: Enhancing Medication Management Through the Use of Clinical Decision Support Software Platforms." Neurology and therapy vol. 8,1 (2019): 79-94. doi: https://doi.org/10.1007/s40120-019-0131-6
Keine D, Zelek M, Walker JQ, Sabbagh MN. Polypharmacy in an Elderly Population: Enhancing Medication Management Through the Use of Clinical Decision Support Software Platforms. Neurol Ther. 2019 Jun;8(1):79-94. doi: 10.1007/s40120-019-0131-6. Epub 2019 Mar 21. PMID: 30900186; PMCID: PMC6534631.
Copy Download .nbib Format: NLM
Identification and estimation of causal effects with outcomes truncated by death.

Biometrika

Wang L, Zhou XH, Richardson TS.
PMID: 29430035
Biometrika. 2017 Sep;104(3):597-612. doi: 10.1093/biomet/asx034. Epub 2017 Jul 11.

It is common in medical studies that the outcome of interest is truncated by death, meaning that a subject has died before the outcome could be measured. In this case, restricted analysis among survivors may be subject to selection...

Cite
Wang L, Zhou XH, Richardson TS. Identification and estimation of causal effects with outcomes truncated by death. Biometrika. 2017;104(3):597-612doi: 10.1093/biomet/asx034.
Wang, L., Zhou, X. H., & Richardson, T. S. (2017). Identification and estimation of causal effects with outcomes truncated by death. Biometrika, 104(3), 597-612. https://doi.org/10.1093/biomet/asx034
Wang, Linbo, et al. "Identification and estimation of causal effects with outcomes truncated by death." Biometrika vol. 104,3 (2017): 597-612. doi: https://doi.org/10.1093/biomet/asx034
Wang L, Zhou XH, Richardson TS. Identification and estimation of causal effects with outcomes truncated by death. Biometrika. 2017 Sep;104(3):597-612. doi: 10.1093/biomet/asx034. Epub 2017 Jul 11. PMID: 29430035; PMCID: PMC5793679.
Copy Download .nbib Format: NLM
Reliability of Medical History Reporting in Older Adults With and Without Cognitive Impairment.

Journal of central nervous system disease

Curcio N, Wilmoth K, LoBue C, Cullum CM.
PMID: 31040738
J Cent Nerv Syst Dis. 2019 Apr 22;11:1179573519843874. doi: 10.1177/1179573519843874. eCollection 2019.

BACKGROUND: Clinical diagnosis of cognitive disorders depends on accurate reporting of medical history, yet little is known about the reliability and the validity of such reports, particularly in older patients with and without cognitive impairment.METHODS: In 2 studies, we...

Cite
Curcio N, Wilmoth K, LoBue C, et al. Reliability of Medical History Reporting in Older Adults With and Without Cognitive Impairment. J Cent Nerv Syst Dis. 2019;11:1179573519843874doi: 10.1177/1179573519843874.
Curcio, N., Wilmoth, K., LoBue, C., & Cullum, C. M. (2019). Reliability of Medical History Reporting in Older Adults With and Without Cognitive Impairment. Journal of central nervous system disease, 111179573519843874. https://doi.org/10.1177/1179573519843874
Curcio, Nicholas, et al. "Reliability of Medical History Reporting in Older Adults With and Without Cognitive Impairment." Journal of central nervous system disease vol. 11 (2019): 1179573519843874. doi: https://doi.org/10.1177/1179573519843874
Curcio N, Wilmoth K, LoBue C, Cullum CM. Reliability of Medical History Reporting in Older Adults With and Without Cognitive Impairment. J Cent Nerv Syst Dis. 2019 Apr 22;11:1179573519843874. doi: 10.1177/1179573519843874. eCollection 2019. PMID: 31040738; PMCID: PMC6477758.
Copy Download .nbib Format: NLM
Whole-exome sequencing in 20,197 persons for rare variants in Alzheimer's disease.

Annals of clinical and translational neurology

Raghavan NS, Brickman AM, Andrews H, Manly JJ, Schupf N, Lantigua R, Wolock CJ, Kamalakaran S, Petrovski S, Tosto G, Vardarajan BN, Goldstein DB, Mayeux R.
PMID: 30009200
Ann Clin Transl Neurol. 2018 May 24;5(7):832-842. doi: 10.1002/acn3.582. eCollection 2018 Jul.

OBJECTIVE: The genetic bases of Alzheimer's disease remain uncertain. An international effort to fully articulate genetic risks and protective factors is underway with the hope of identifying potential therapeutic targets and preventive strategies. The goal here was to identify...

Cite
Raghavan NS, Brickman AM, Andrews H, et al. Whole-exome sequencing in 20,197 persons for rare variants in Alzheimer's disease. Ann Clin Transl Neurol. 2018;5(7):832-842doi: 10.1002/acn3.582.
Raghavan, N. S., Brickman, A. M., Andrews, H., Manly, J. J., Schupf, N., Lantigua, R., Wolock, C. J., Kamalakaran, S., Petrovski, S., Tosto, G., Vardarajan, B. N., Goldstein, D. B., Mayeux, R. (2018). Whole-exome sequencing in 20,197 persons for rare variants in Alzheimer's disease. Annals of clinical and translational neurology, 5(7), 832-842. https://doi.org/10.1002/acn3.582
Raghavan, Neha S, et al. "Whole-exome sequencing in 20,197 persons for rare variants in Alzheimer's disease." Annals of clinical and translational neurology vol. 5,7 (2018): 832-842. doi: https://doi.org/10.1002/acn3.582
Raghavan NS, Brickman AM, Andrews H, Manly JJ, Schupf N, Lantigua R, Wolock CJ, Kamalakaran S, Petrovski S, Tosto G, Vardarajan BN, Goldstein DB, Mayeux R. Whole-exome sequencing in 20,197 persons for rare variants in Alzheimer's disease. Ann Clin Transl Neurol. 2018 May 24;5(7):832-842. doi: 10.1002/acn3.582. eCollection 2018 Jul. PMID: 30009200; PMCID: PMC6043775.
Copy Download .nbib Format: NLM
Sex as a Risk Factor for Developing Cognitive Impairments in National Alzheimer's Coordinating Center Participants.

Journal of Alzheimer's disease reports

Wang G, Li W.
PMID: 33681711
J Alzheimers Dis Rep. 2021 Jan 11;5(1):1-6. doi: 10.3233/ADR-200275.

BACKGROUND: It is inconclusive on how sex affects the risk of developing mild cognitive impairment (MCI) or dementia.OBJECTIVE: To investigate how sex affects the risk of developing MCI or dementia.METHODS: A secondary data analysis was performed on data collected...

Cite
Wang G, Li W. Sex as a Risk Factor for Developing Cognitive Impairments in National Alzheimer's Coordinating Center Participants. J Alzheimers Dis Rep. 2021;5(1):1-6doi: 10.3233/ADR-200275.
Wang, G., & Li, W. (2021). Sex as a Risk Factor for Developing Cognitive Impairments in National Alzheimer's Coordinating Center Participants. Journal of Alzheimer's disease reports, 5(1), 1-6. https://doi.org/10.3233/ADR-200275
Wang, Ge, and Li, Wei. "Sex as a Risk Factor for Developing Cognitive Impairments in National Alzheimer's Coordinating Center Participants." Journal of Alzheimer's disease reports vol. 5,1 (2021): 1-6. doi: https://doi.org/10.3233/ADR-200275
Wang G, Li W. Sex as a Risk Factor for Developing Cognitive Impairments in National Alzheimer's Coordinating Center Participants. J Alzheimers Dis Rep. 2021 Jan 11;5(1):1-6. doi: 10.3233/ADR-200275. PMID: 33681711; PMCID: PMC7902986.
Copy Download .nbib Format: NLM
Comprehensive Evaluation of the Functional Activities Questionnaire (FAQ) and Its Reliability and Validity.

Assessment

González DA, Gonzales MM, Resch ZJ, Sullivan AC, Soble JR.
PMID: 33543638
Assessment. 2021 Feb 05;1073191121991215. doi: 10.1177/1073191121991215. Epub 2021 Feb 05.

The Functional Activities Questionnaire (FAQ) is a collateral-report measure of difficulties in activities of daily living. Despite its widespread use, psychometric analyses have been limited in scope, piecemeal across samples, and limited primarily to classical test theory. This article...

Cite
González DA, Gonzales MM, Resch ZJ, et al. Comprehensive Evaluation of the Functional Activities Questionnaire (FAQ) and Its Reliability and Validity. Assessment. 2021;1073191121991215doi: 10.1177/1073191121991215.
González, D. A., Gonzales, M. M., Resch, Z. J., Sullivan, A. C., & Soble, J. R. (2021). Comprehensive Evaluation of the Functional Activities Questionnaire (FAQ) and Its Reliability and Validity. Assessment, 1073191121991215. https://doi.org/10.1177/1073191121991215
González, David Andrés, et al. "Comprehensive Evaluation of the Functional Activities Questionnaire (FAQ) and Its Reliability and Validity." Assessment vol. (2021): 1073191121991215. doi: https://doi.org/10.1177/1073191121991215
González DA, Gonzales MM, Resch ZJ, Sullivan AC, Soble JR. Comprehensive Evaluation of the Functional Activities Questionnaire (FAQ) and Its Reliability and Validity. Assessment. 2021 Feb 05;1073191121991215. doi: 10.1177/1073191121991215. Epub 2021 Feb 05. PMID: 33543638; PMCID: PMC8339133.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 137 entries